Dapsone 25 mg
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
83098-102 -
Package NDC
83098-102-01 -
Package NDC
83098-102-03 -
Application number
ANDA086841 -
SPL ID
5f0576dc-ff08-21b7-e063-6394a90a4397 -
SPL set ID
1d026bb6-05da-e9cf-e063-6394a90a2485 -
UNII
8W5C518302 -
RxCUI
197557 -
RxCUI
197558
What the source publishes
- Labeler
- Everest Life Sciences. LLC
- Active ingredients
- Dapsone Tablets
- Form
- TABLET
- Routes
- ORAL
- Administrative status
- present-in-source-snapshot
- Marketing status
- ANDA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "Dapsone 25 mg",
"splId": "5f0576dc-ff08-21b7-e063-6394a90a4397",
"labels": [
{
"setId": "1d026bb6-05da-e9cf-e063-6394a90a2485",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=1d026bb6-05da-e9cf-e063-6394a90a2485",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=1d026bb6-05da-e9cf-e063-6394a90a2485"
}
],
"routes": [
"ORAL"
],
"labeler": "Everest Life Sciences. LLC",
"finished": true,
"packaging": [
{
"sample": false,
"description": "100 TABLET in 1 BOTTLE (83098-102-01)",
"package_ndc": "83098-102-01",
"identifierStatus": "well-formed",
"marketing_start_date": "20240901"
},
{
"sample": false,
"description": "30 TABLET in 1 BOTTLE (83098-102-03)",
"package_ndc": "83098-102-03",
"identifierStatus": "well-formed",
"marketing_start_date": "20240901"
}
],
"productId": "83098-102_5f0576dc-ff08-21b7-e063-6394a90a4397",
"useDomain": "unknown",
"dosageForm": "TABLET",
"productNdc": "83098-102",
"deaSchedule": null,
"genericName": "Dapsone Tablets",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "DAPSONE",
"strength": "25 mg/1"
}
],
"applicationNumber": "ANDA086841",
"marketingCategory": "ANDA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20240901",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"nui": [
"N0000175881",
"M0020791"
],
"unii": [
"8W5C518302"
],
"rxcui": [
"197557",
"197558"
],
"spl_set_id": [
"1d026bb6-05da-e9cf-e063-6394a90a2485"
],
"pharm_class_cs": [
"Sulfones [CS]"
],
"pharm_class_epc": [
"Sulfone [EPC]"
],
"manufacturer_name": [
"Everest Life Sciences. LLC"
],
"is_original_packager": [
true
]
},
"listingExpirationDate": "20271231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:83098-102_5f0576dc-ff08-21b7-e063-6394a90a4397"